Cells in largely non-mitotic tissues such as the brain are prone to stochastic (epi-)genetic alterations 19 that may cause increased variability between cells and individuals over time. Although increased inter-20 individual heterogeneity in gene expression was previously reported, whether this process starts during 21 development or if it is restricted to the aging period has not yet been studied. The regulatory dynamics 22 and functional significance of putative aging-related heterogeneity are also unknown. Here we address 23 these by a meta-analysis of 19 transcriptome datasets from diverse human brain regions. We observed 24 a significant increase in inter-individual heterogeneity during aging (20+ years) compared to postnatal 25 development (0 to 20 years). Increased heterogeneity during aging was consistent among different 26 brain regions at the gene level and associated with lifespan regulation and neuronal functions. Overall, 27 our results show that increased expression heterogeneity is a characteristic of aging human brain, and 28 may influence aging-related changes in brain functions.
89
pre-adulthood and adulthood based on commonly used age intervals in earlier studies (see Methods).
90
For the analysis, we focused only on the genes for which we have a measurement across all datasets 91 (n = 11,137).
93

Age-related change in gene expression levels 94
To quantify age-related changes in gene expression, we used a linear model between gene expression 95 levels and age (see Methods, Supplementary Fig. S2 ). We transformed the ages to the fourth root scale 96 before fitting the model as it provides relatively uniform distribution of sample ages across the lifespan, 97 but we also confirmed that different age scales yield quantitatively similar results (see Supplementary 98 Fig. S3 ). We quantified expression change of each gene in aging and development periods separately 99 and considered regression coefficients from the linear model (β values) as a measure of age-related 100 expression change ( Supplementary Fig. S4 ).
6
We next asked if datasets show similar r, i.e. age-related changes in heterogeneity, by calculating 158 pairwise Spearman's correlation between pairs of datasets, across shared genes (Figure 2a ). Unlike 159 the correlations among expression level changes, r values did not show a higher consistency during 160 development. In fact, although the difference is not significant (permutation test p = 0.2, Supplementary 161 Fig. S6 ), the median value of the correlation coefficients was higher in aging (median correlation 162 coefficient = 0.21, permutation test p = 0.24, Supplementary Fig. S5 ), than in development (median 163 correlation coefficient = 0.11, permutation test p = 0.25, Supplementary Fig. S5 ).
165
A principal component analysis (PCA) showed that, like expression change, heterogeneity change with 166 age can also differentiate aging datasets from development (Figure 2b ). Similar to the pairwise 167 correlations (Figure 2a ), aging datasets clustered more closely than development datasets (median 168 pairwise Euclidean distances between PC1 and PC2 are 41 and 44 for aging and development, 169 respectively). Both observations imply more similar changes in heterogeneity during aging.
171
Using the p-values from Spearman's correlation between age and the absolute value of residuals for 172 each gene, we then investigated the genes showing a significant change in heterogeneity during aging 173 and development (FDR corrected p-value < 0.05). We found almost no significant change in 174 heterogeneity during development, except for the Colantuoni2011 dataset, for which we have high 175 statistical power due to its large sample size. In aging datasets, on the other hand, we observed more 176 genes with significant changes in heterogeneity (permutation test p = 0.06, Supplementary Fig. S6 ) and 177 the majority of the genes with significant changes in heterogeneity tended to increase in heterogeneity 178 ( Figure 2c) . However, the genes showing a significant change did not overlap across aging datasets 179 ( Supplementary Fig. S8 ).
181
Nevertheless, our analyses indicated relatively more consistent heterogeneity changes among datasets 182 in aging compared to development, implying that heterogeneity change could be a characteristic linked for the dependence among datasets and is more stringent than random permutations (see Supplementary Fig. S10 214 for details).
216
We first examined profiles of age-related heterogeneity change in aging and development. Among 217 aging datasets 18/19 showed more increase than decrease in heterogeneity with age (median r > 0, 218 i.e. higher numbers of genes with increase), while the median heterogeneity change in one dataset was 219 zero. In development, on the other hand, only 5/19 datasets showed more increase in heterogeneity, 220 9 while the remaining 14/19 datasets showed more decrease with age (median r < 0) ( Figure 3a ). The 221 age-related change in heterogeneity during aging was significantly higher than during development 222 (permutation test p < 0.001, Supplementary Fig. S6 ). We also checked if there is a relationship between 223 changes in heterogeneity during development and during aging (e.g. if those genes that decrease in 224 heterogeneity tend to increase in heterogeneity during aging) but did not find any significant trend 225 ( Supplementary Fig. S9 ).
227
A potential explanation why we see different patterns of heterogeneity change with age in development 228 and aging could be the accompanying changes in the expression levels, as it is challenging to remove 229 dependence between the mean and variance. To address this possibility, we first calculated 
236
Having observed both a tendency to increase and a higher consistency in heterogeneity change during 237 aging, we asked which genes show consistent increase in heterogeneity across datasets in aging and 238 development. We therefore calculated the number of datasets with an increase in heterogeneity during 239 development and aging for each gene (Figure 3c ). To calculate significance and expected consistency, 240 while controlling for dataset dependence, we performed 1,000 random permutations of individuals' ages 241 and re-calculated the heterogeneity changes (see Methods). In development, there was no significant 242 consistency in heterogeneity change in either increase or decrease. During aging, however, there was 243 a significant signal of consistent heterogeneity increase, i.e. more genes showed consistent 244 heterogeneity increase across aging datasets than randomly expected (Figure 3c , lower panel). We 245 identified 147 common genes with a significant increase in heterogeneity across all aging datasets 246 (permutation test p < 0.001, Supplementary Table S2 ). Based on our permutations, we estimated that 247 84/147 genes could be expected to have consistent increase just by chance, suggesting only ~40% 248 true positives. In development, in contrast, there was no significant consistency in heterogeneity change 249 in either direction (increase or decrease). Nevertheless, comparing the consistency in aging and 250 development, there was an apparent shift towards a consistent increase in aging -even if we cannot 251 confidently report the genes that become significantly more heterogeneous with age across multiple 252 datasets.
254
Heterogeneity Trajectories
255
We next asked if there are specific patterns of heterogeneity change, e.g. increase only after a certain 256 age. We used the genes with a consistent increase in heterogeneity with age during aging (n = 147) to 257 explore the trajectories of heterogeneity change (Figure 4 ). Genes grouped with k-means clustering 10 revealed three main patterns of heterogeneity increase ( Supplementary Table S2 ): i) genes in clusters 259 3 and 7 show noisy but a steady increase throughout aging, ii) genes in clusters 4, 5 and 8 show 260 increase in early aging but a later slight decrease, revealing a reversal (up-down) pattern, and iii) the 261 remaining genes in cluster 1, 2 and 6 increase in heterogeneity dramatically after the age of 60. We 262 next asked if these genes have any consistent heterogeneity change pattern in development 263 ( Supplementary Fig. S11 ), but most of the clusters showed no or only weak age-related changes during 264 development. We also analyzed the accompanying changes in mean expression levels for these 265 clusters. Except for cluster 1, which shows a decrease in expression level at around the age of 60 and 266 then shows a dramatic increase, all clusters show a steady scaled mean expression level at around 267 zero, i.e. different genes in a cluster show different patterns ( Supplementary Fig. S12 ).
269
We further tested the genes showing dramatic heterogeneity increase after the age of 60 (clusters 1, 2 270 and 6) for association with Alzheimer's Disease, as the disease incidence increases after 60 25 as well; 271 however, we found no evidence for such an association (see Supplementary Fig. S13 ). 
281
Functional analysis 282
To examine the functional associations of heterogeneity changes with age, we performed gene set 283 enrichment analysis using KEGG pathways 26 , Gene Ontology (GO) categories 27,28 , Disease Ontology 284 11 (DO) categories 29 , Reactome pathways 30 , transcription factor (TF) targets (TRANSFAC) 31 , and miRNA 285 targets (MiRTarBase) 32 . Specifically, we rank-ordered genes based on the number of datasets that 286 show a consistent increase in heterogeneity and asked if the extremes of this distribution are associated 287 with the gene sets that we analyzed. There was no significant enrichment for any of the functional 288 categories and pathways for the consistent changes in development. The significantly enriched KEGG 289 pathways for the genes that become consistently heterogeneous during aging included multiple KEGG 290 pathways known to be relevant for aging, including the longevity regulating pathway, autophagy 33 , 291 mTOR signaling 34 and FoxO signaling 35 (Figure 5a ). Among the pathways with a significant association 292 (listed in Figure 5a ), only protein digestion and absorption, primary immunodeficiency, linoleic acid 293 metabolism, and fat digestion and absorption pathways had negative enrichment scores, meaning 294 these pathways were significantly associated with the genes having the least number of datasets
295
showing an increase. However, it is important to note that this does not mean these pathways have a 296 decrease in heterogeneity as the distribution of consistent heterogeneity levels is skewed (Figure 3c , 297 lower panel). We also calculated if the KEGG pathways that we identified are particularly enriched in 298 any of the heterogeneity trajectories we identified. Although we lack the necessary power to test the 299 associations statistically due to small number of genes, we saw that i) group 1, which showed a stable 300 increase in heterogeneity, is associated more with the metabolic pathways and mRNA surveillance 301 pathway, ii) group 2, which showed first an increase and a slight decrease at later ages, is associated 302 with axon guidance, mTOR signaling, and phospholipase D signaling pathways, and iii) group 3, which 303 showed a dramatic increase after age of 60, is associated with autophagy, longevity regulating pathway line shows x = 9.5, which is the middle point for 19 datasets, representing no tendency to increase or decrease.
311
Values higher than 9.5, shown with red color, indicate an increase in heterogeneity while values lower than 9.5, 12 shown with blue color, indicate a decrease in heterogeneity and the darkness shows the consistency in change 313 across datasets. b) The longevity regulating pathway (KEGG Pathway ID: hsa04211), exemplifying the distribution 314 of the genes (circles), their heterogeneity across datasets (color -the same color scheme as panel (a)), and their 315 relationship in the pathway (edges). More detailed schemes for all significant pathways with the gene names are 316 given as SI.
318
The distribution of consistent heterogeneity in development and aging also showed a clear difference.
319
The pathway scheme for the longevity regulating pathway (Figure 5b) , colored based on the number of 320 datasets with a consistent increase, shows how particular genes compare between development and Supplementary Table S10 ), we detected a significant enrichment for the genes that become more 326 heterogeneous during aging, with the exception that Disease Ontology terms were not significantly 327 associated with consistent changes in either development or aging. The gene sets included specific 328 categories such as autophagy and synaptic functions as well as broad functional categories such as 329 regulation of transcription and translation processes, cytoskeleton or histone modifications. We also 330 performed GSEA for each dataset separately and confirmed that these pathways show consistent 331 patterns in aging (Supplementary Figs. S15-S19). There were 30 significantly enriched transcription 332 factors, including EGR and FOXO, and 99 miRNAs (see Supplementary Table S8 -9 for the full list). We 333 also asked if the genes that become more heterogenous consistently across datasets are known aging-334 related genes, using the GenAge Human gene set 36 , but did not find a significant association 335 ( Supplementary Fig. S20 ).
337
It has been reported that the total number of distinct regulators of a gene (apart from its specific 338 regulators) is correlated with gene expression noise 37 . Accordingly, we asked if the total number of 339 transcription factors (TFs) or miRNAs regulating a gene might be related to the heterogeneity change 340 with age ( Figure 6 ). We calculated the correlations between the total number of regulators and the 341 heterogeneity changes and found a mostly positive (18 / 19 for miRNA and 15 / 19 for TFs), and higher 342 correlation between change in heterogeneity and the number of regulators in aging (p = 0.007 for 343 miRNA and p = 0.045 TFs). We further tested the association while controlling for the expression 344 changes in development and aging since regulation of expression changes during development could 345 confound a relationship. However, we found that the pattern is mainly associated with the genes that 
354
We further tested if genes with a consistent heterogeneity increase in aging are more central in the 355 protein interaction network using STRING database 38 . Using multiple cutoffs and repeating the analysis,
356
we observed a higher degree of interactions for the genes with increasing heterogeneity 357 ( Supplementary Fig. S22 ).
359
Johnson and Dong et al. previously compiled a list of traits that are age-related and have been 360 sufficiently tested for genome-wide associations (n = 39) 39 . Using the genetic associations for GWAS
361
Catalog traits, we tested if there are significantly enriched traits for the consistent changes in 362 heterogeneity during aging ( Supplementary Table S11 ). Although there was no significant enrichment, 363 all these age-related terms had positive enrichment scores, i.e. they all tended to include genes that 364 consistently become more heterogeneous with age during aging.
366
Using cell-type specific transcriptome data generated from FACS-sorted cells in mouse brain 40 , we also 367 analyzed if there is an association between genes that become heterogeneous with age and cell-type 368 specific genes, which could be expected if brain cell-type composition progressively varied among 369 individuals with age. Although there was an overlap with oligodendrocytes and myelinated 370 oligodendrocytes, there was no significant enrichment (which could be attributed to low power due to 371 small overlap between aging and cell-type specific expression datasets) ( Supplementary Fig. S23 ).
373
Discussion 374
Aging is characterized by a gradual decrease in the ability to maintain homeostatic processes, which 375 leads to functional decline, age-related diseases, and eventually to death. This age-related 376 deterioration, however, is thought as not a result of expression changes in a few individual genes, but 377 rather as a consequence of an age-related alteration of the whole genome, which could be a result of 378 an accumulation of both epigenetic and genetic errors in a stochastic manner 23,41 . This stochastic nature 379 of aging impedes the identification of conserved age-related changes in gene expression from a single 380 dataset with a limited number of samples.
382
In this study, we examined 19 gene expression datasets compiled from three independent studies to 383 identify the changes in gene expression heterogeneity with age. While all datasets have samples 384 representing the whole lifespan, we separated postnatal development (0 to 20 years of age) and aging 385 (20 to 98 years of age) by the age of 20, as this age is considered to be a turning-point in gene 386 expression trajectories 13 . We implemented a regression-based method and identified genes showing a 387 consistent change in heterogeneity with age, during development and aging separately. At the single 388 gene level, we did not observe significant age-related heterogeneity change in most of the datasets, 389 possibly due to insufficient statistical power due to small sample sizes and the subtle nature of the 390 phenomenon. We hence took advantage of a meta-analysis approach and focused on consistent 391 signals among datasets, irrespective of their effect sizes and significance. Although this approach fails 392 to capture patterns that are specific to individual brain regions, it identifies genes that would otherwise 393 not pass the significance threshold due to insufficient power. Furthermore, we demonstrated that our 394 method is robust to noise and confounding effects within individual datasets.
396
By analyzing age-related gene expression changes, we first observed that there are more significant 397 and more similar changes during development than aging. Additionally, genes showing significant 398 change during aging tended to decrease in expression ( Figure 1) . These results can be explained by 399 the accumulation of stochastic detrimental effects during aging, leading to a decrease in expression 400 levels 2 . Our initial analysis of gene expression changes suggested a higher heterogeneity between 401 aging datasets.
403
We next focused on age-related heterogeneity change between individuals and found a significant 404 increase in age-related heterogeneity during aging, compared to development. Notably, increased 405 heterogeneity is not limited to individual brain regions, but a consistent pattern across different regions 406 during aging. We found that age-related heterogeneity change is more consistent among aging 407 datasets, which may reflect an underlying systemic mechanism. Further, a larger number of genes 408 showed more significant heterogeneity changes during aging than in development, and the majority of 409 these genes tended to have more heterogeneous expression.
411
It was previously proposed that somatic mutation accumulations 2,41-43 and epigenetic regulations 44 
415
we cannot test age-related somatic mutation accumulation and epigenetic regulation in this study, an 416 alternative mechanism might be related to transcriptional regulation, which is considered to be 417 inherently stochastic 46 . Several studies demonstrated that variation in gene expression is positively 418 correlated with the number of TFs controlling gene's regulation 37 . We also found that genes with a 419 higher number of regulators and a decrease in expression during aging become more heterogeneous.
420
Further, significantly enriched TFs include early growth response (EGF), known to be regulating the 421 expression of many genes involved in synaptic homeostasis and plasticity, and FOXO TFs, which 422 regulate stress resistance, metabolism, cell cycle arrest and apoptosis. Together with these studies,
423
our results support that transcriptional regulation may be associated with age-related heterogeneity 424 increase during aging and may have important functional consequences in brain aging.
426
We next confirmed that observed increase in heterogeneity was not a result of low statistical power 427 ( Supplementary Fig. S1 ) or a technical artifact (Figure 3b, Supplementary Figs. S24-S25) . Specifically,
428
we tested whether increased heterogeneity during aging can be a result of the mean-variance 429 relationship, but we found no significant effect that can confound our results. In fact, the mean-variance 430 relationship in development and aging showed opposing profiles. We further analyzed this by grouping 431 genes based on their expression in development and aging ( Supplementary Fig. S24 ). The genes that 432 decrease in expression both in development and aging showed the most opposing profiles in terms of 433 the mean-variance relationship, which could suggest that the decrease in development are more 434 coordinated and well-regulated whereas the decrease in aging occurs due to stochastic errors. Another 435 potential confounder is the post-mortem interval (PMI), which is the time between death and sample 436 collection. Since we do not have this data for all datasets we analyzed, we could not account for PMI 437 in our model. However, using the list of genes previously suggested as associated with PMI 47 , we 438 checked if the consistency among aging datasets could be driven by PMI. Only 2 PMI-associated genes 439 were among the 147 that become consistently heterogeneous, and the distribution also suggested there 440 is no significant relationship ( Supplementary Fig. S25 ). We also confirmed that the increase in 441 heterogeneity is not caused by outlier samples in datasets ( Supplementary Fig. S26 ) or by the confound 442 of sex with age ( Supplementary Fig. S27 ).
444
One important limitation of our study is that we analyze microarray-based data. Since gene expression 445 levels measured by microarray do not reflect an absolute abundance of mRNAs, but rather are relative 446 expression levels, we were only able to examine relative changes in gene expression. A recent study 447 analyzing single-cell RNA sequencing data from the aging Drosophila brain identified an age-related 448 decline in total mRNA abundance 48 . It is also suggested that, in microarray studies, genes with lower 449 expression levels tend to have higher variance 49 . In this context, whether the change in heterogeneity 16 critical because it affects hub genes, another explanation is research bias that these genes are studied 490 more than others.
492
In summary, by performing a meta-analysis of transcriptome data from diverse brain regions we found 493 a significant increase in gene expression heterogeneity during aging, compared to development.
494
Increased heterogeneity was a consistent pattern among diverse brain regions in aging, while no 495 significant consistency was observed across development datasets. Our results support the view of 496 aging as a result of stochastic molecular alterations, whilst development has a higher degree of gene 497 expression regulation. We also found that genes showing a consistent increase in heterogeneity during 498 aging are involved in pathways important for aging and neuronal function. Therefore, our results 499 demonstrate that increased heterogeneity is one of the characteristics of brain aging and is unlikely to 
505
In this study, we performed re-analysis of publicly available transcriptome datasets to test age-related 506 change in gene expression heterogeneity. All data collection in these previous studies were performed 507 in accordance with relevant guidelines, regulations and approved experimental protocols, including 508 informed consents for the use of samples for research from all donors or their next of kin.
509
Microarray datasets: Raw data used in this study were retrieved from the NCBI Gene Expression 510 Omnibus (GEO) from three different sources ( Supplementary Table S1 ). All three datasets consist of 511 human brain gene expression data generated on microarray platforms. In total, we obtained 1017 512 samples from 298 individuals, spanning the whole lifespan with ages ranging from 0 to 98 years 513 ( Supplementary Fig. S1 ).
514
RNA sequencing dataset: We used the transcriptome data generated by the GTEx Consortium (v6p) 50 .
515
We only used the samples with a death circumstance of 1 (violent and fast deaths due to an accident) 516 and 2 (fast death of natural causes) on the Hardy Scale excluding individuals who died of illnesses. As 517 we focus only on the brain, we used all 13 brain tissue data in GTEx. We thus analyzed 623 samples 518 obtained from 99 individuals.
519
Separating datasets into development and aging datasets: To differentiate changes in gene expression 520 heterogeneity during aging from those during development, we used the age of 20 to separate pre-521 adulthood from adulthood. It was shown that the age of 20 corresponds to the first age of reproduction 522 in human societies 52 . Structural changes after the age of 20 in the human brain were previously linked 523 to age-related phenotypes, specifically neuronal shrinkage and a decline in total length of myelinated 524 fibers 3 . Earlier studies examining age-related gene expression changes in different brain regions also 525 showed a global change in gene expression patterns after the age of 20 11, 13, 53 . Thus, consistent with these studies, we separated datasets using the age of 20 into development (0 to 20 years of age, n = 527 441) and aging (20 to 98 years of age, n = 569).
529
Preprocessing 530 Microarray datasets: RMA correction (using the 'oligo' library in R) 54 and log2 transformation were 531 applied to Somel2011 and Kang2011 datasets. For the Colantuoni2011 dataset, as there was no public 532 R package to analyze the raw data, we used the preprocessed data deposited in GEO, which had been 533 loess normalized by the authors. We quantile normalized all datasets using the 'preprocessCore' library 534 in R 55 . Notably, our analysis focused on consistent patterns across datasets, instead of considering 535 significant changes within individual datasets. Since we don't expect random confounding factors to be 536 shared among datasets, we used quantile normalization to minimize the effects of confounders, and we 537 treated consistent results as potentially a biological signal. We also applied an additional correction 538 procedure for Somel2011 datasets, in which there was a batch effect influencing the expression levels, 539 as follows: for each probeset (1) calculate mean expression (M), (2) scale each batch separately (to 540 mean = 0, standard deviation = 1), (3) add M to each value. We excluded outliers given in 541 Supplementary Table S1 , through a visual inspection of the first two principal components for the 543 Dönertaş et al., 2017) . We mapped probeset IDs to Ensembl gene IDs 1) using the Ensembl database, 544 through the 'biomaRt' library 57 in R for the Somel2011 dataset, 2) using the GPL file deposited in GEO 545 for Kang2011, as probeset IDs for this dataset were not complete in Ensembl, and 3) using the Entrez 546 gene IDs in the GPL file deposited in GEO for the Colantuoni2011 dataset and converting them into 547 Ensembl gene IDs using the Ensemble database, through the "biomaRt" library in R. Lastly, we scaled 548 expression levels for genes (to mean = 0, standard deviation = 1) using the 'scale' function in R. Age 549 values of individuals in each dataset were converted to the fourth root of age (in days) to have a linear 550 relationship between age and expression both in development and aging. However, we repeated the 551 analysis using different age scales and confirmed that the results were quantitatively similar 552 ( Supplementary Fig. S3 ).
553
RNA sequencing dataset: The genes with median RPKM value of 0 were excluded from the dataset.
554
The RPKM values provided in the GTEx data were log2 transformed and quantile-normalized. Similar 555 to the microarray data, we excluded the outliers based on the visual inspection of the first and second 556 principal components ( Supplementary Table S1 ). In GTEx, ages are given as 10 year intervals. We 557 therefore used the middle point of these age intervals to represent that individual's age.
559 560
Age-related expression change
561
We used linear regression to assess the relationship between age and gene expression. The model where Yi is the scaled log2 expression level for the i th gene, βi0 is the intercept, βi1 is the slope, and εi is 567 the residual. We performed the analysis for each dataset (development and aging datasets separately) 568 and considered the β1 value as a measure of change in expression. 
585
We conducted principal component analysis on both age-related changes in expression (β) and 586 heterogeneity (r). We followed a similar procedure for both analyses, in which we used the 'prcomp' 
592
Permutation test
593
We performed a permutation test, taking into account the non-independence of samples across the 594 Somel2011 and Kang2011 datasets, due to the fact that these datasets include multiple samples from 595 the same individuals for different brain regions. We first randomly permuted ages among individuals, 596 not samples, for 1,000 times in each data source, using the 'sample' function in R. Next, we assigned 597 ages of individuals to corresponding samples and calculated age-related expression and heterogeneity 598 change for each dataset, corresponding to different brain regions. For the tests related to the changes 599 in gene expression with age, we used a linear model between gene expression levels and the 600 randomized ages. In contrast, for the tests related to the changes in heterogeneity with age, we 601 measured the correlation between the randomized ages and the absolute value of residuals from the 602 linear model that is between expression levels and non-randomized ages for each gene. In this way, 603 20 we preserved the relationship between age and expression, and we were able to ensure that our 
611
if the observed consistency in heterogeneity increase is significantly different from expected. All tests 612 using permuted ages were performed one-tailed. We also demonstrate that our permutation strategy is 613 more stringent than random permutations in Supplementary Figure S10 , giving the distributions 614 calculated using both dependent permutations and random permutations.
616
To test the overall correlation within development or aging datasets for the changes in expression (b) 617 and heterogeneity (r), we calculated median correlations among independent three subsets of datasets 618 (one Kang2011, one Somel2011 and the Colantuoni2011 dataset), taking the median value calculated 619 for each possible combination of independent subsets (16 x 2 x 1 = 32 combinations). Using 1,000 620 permutations of individuals' ages, we generated an expected distribution for the median correlation 621 coefficient for triples and compared these with the observed values, asking how many times we observe 622 a higher value. We used this approach to calculate expected median correlation among development 623 (and aging) datasets, because the number of independent pairwise comparisons are outnumbered by 624 the number of dependent pairwise comparisons, causing low statistical power.
626
To further test the significance of the difference between correlations among development and aging 627 datasets, we calculated the median difference in correlations between aging and development datasets 628 for each permutation. We next constructed the null distribution of 1,000 median differences and 629 calculated empirical p-values compering the observed differences with these null distributions. Next, to
